Nine Ten Capital Management LLC Maxcyte, Inc. Transaction History

Nine Ten Capital Management LLC

  • $260 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$5.26 - $10.84 $9.83 Million - $20.3 Million
-1,868,597 Closed
0 $0
Q4 2021

Feb 09, 2022
SELL
$8.87 - $12.94 $287,130 - $418,880
-32,371 Reduced 1.7%
1,868,597 $19 Million
Q3 2021

Nov 12, 2021
BUY
$12.21 - $17.2 $23.2 Million - $32.7 Million
1,900,968 New
1,900,968 $23.2 Million

Others Institutions Holding MXCT

# of Institutions
118
Shares Held
65.2M
Call Options Held
600
Put Options Held
2.7K
View Full List

About MAXCYTE, INC.

MXCT Quotes by TradingView
  • Ticker MXCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 101,724,000
  • Market Cap $395M
  • Description
  • MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...
More about MXCT
Track This Portfolio

Track Nine Ten Capital Management LLC Portfolio

Follow Nine Ten Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nine Ten Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nine Ten Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email